Alnylam Pharmaceuticals Inc (ALNY)
150.42
+1.99
(+1.34%)
USD |
NASDAQ |
Jun 03, 16:00
150.42
0.00 (0.00%)
After-Hours: 19:52
Alnylam Pharmaceuticals Cash and Short Term Investments (Quarterly): 2.371B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.371B |
December 31, 2023 | 2.439B |
September 30, 2023 | 2.406B |
June 30, 2023 | 2.058B |
March 31, 2023 | 2.071B |
December 31, 2022 | 2.192B |
September 30, 2022 | 2.265B |
June 30, 2022 | 2.111B |
March 31, 2022 | 2.240B |
December 31, 2021 | 2.436B |
September 30, 2021 | 2.328B |
June 30, 2021 | 1.900B |
March 31, 2021 | 1.710B |
December 31, 2020 | 1.874B |
September 30, 2020 | 1.834B |
June 30, 2020 | 1.926B |
March 31, 2020 | 1.342B |
December 31, 2019 | 1.536B |
September 30, 2019 | 1.721B |
June 30, 2019 | 1.927B |
March 31, 2019 | 1.245B |
December 31, 2018 | 1.084B |
September 30, 2018 | 1.237B |
June 30, 2018 | 1.448B |
March 31, 2018 | 1.568B |
Date | Value |
---|---|
December 31, 2017 | 1.691B |
September 30, 2017 | 948.29M |
June 30, 2017 | 923.27M |
March 31, 2017 | 559.60M |
December 31, 2016 | 626.80M |
September 30, 2016 | 713.14M |
June 30, 2016 | 856.40M |
March 31, 2016 | 1.014B |
December 31, 2015 | 1.081B |
September 30, 2015 | 1.016B |
June 30, 2015 | 1.005B |
March 31, 2015 | 1.067B |
December 31, 2014 | 696.69M |
September 30, 2014 | 631.93M |
June 30, 2014 | 654.76M |
March 31, 2014 | 665.49M |
December 31, 2013 | 245.87M |
September 30, 2013 | 193.78M |
June 30, 2013 | 209.69M |
March 31, 2013 | 236.01M |
December 31, 2012 | 122.81M |
September 30, 2012 | 228.34M |
June 30, 2012 | 229.02M |
March 31, 2012 | 199.10M |
December 31, 2011 | 146.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.342B
Minimum
Mar 2020
2.439B
Maximum
Dec 2023
2.034B
Average
2.064B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Pfizer Inc | 11.93B |
BridgeBio Pharma Inc | 519.69M |
Cytokinetics Inc | 618.96M |
Ionis Pharmaceuticals Inc | 2.206B |
Madrigal Pharmaceuticals Inc | 1.059B |